|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2007-3-30
|
|
pubmed:abstractText |
Iron is essential for proliferation of normal and neoplastic cells. Cellular iron uptake, utilization and storage are regulated by transcriptional and post-transcriptional mechanisms. We hypothesized that the disruption of iron homeostasis may modulate the growth properties of cancer cells. To address this, we employed H1299 lung cancer cells engineered for tetracycline-inducible overexpression of the post-transcriptional regulator iron regulatory protein 1 (IRP1). The induction of IRP1 (wild-type or the constitutive IRP1(C437S) mutant) did not affect the proliferation of the cells in culture, and only modestly reduced their efficiency to form colonies in soft agar. However, IRP1 dramatically impaired the capacity of the cells to form solid tumor xenografts in nude mice. Tumors derived from IRP1-transfectants were <20% in size compared to those from parent cells. IRP1 coordinately controls the expression of transferrin receptor 1 (TfR1) and ferritin by binding to iron-responsive elements (IREs) within their mRNAs. Biochemical analysis revealed high expression of epitope-tagged IRP1 in tumor tissue, which was associated with a profound increase in IRE-binding activity. As expected, this response misregulated iron metabolism by increasing TfR1 levels. Surprisingly, IRP1 failed to suppress ferritin expression and did not affect the levels of the iron transporter ferroportin. Our results show that the overexpression of IRP1 is associated with an apparent tumor suppressor phenotype and provide a direct regulatory link between the IRE/IRP system and cancer.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/17127713-11106561,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17127713-11885287,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17127713-11978485,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17127713-11991946,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17127713-12052872,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17127713-12160928,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17127713-12242109,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17127713-12396663,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17127713-1502165,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17127713-15105251,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17127713-15109490,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17127713-15313461,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17127713-15459663,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17127713-15508107,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17127713-15604406,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17127713-15636585,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17127713-16148948,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17127713-16508012,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17127713-16757684,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17127713-4442124,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17127713-6309829,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17127713-7508861,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17127713-7665579,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17127713-8349646,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17127713-9924025
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0143-3334
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
28
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
785-91
|
|
pubmed:dateRevised |
2010-9-24
|
|
pubmed:meshHeading |
pubmed-meshheading:17127713-Aconitate Hydratase,
pubmed-meshheading:17127713-Animals,
pubmed-meshheading:17127713-Blotting, Western,
pubmed-meshheading:17127713-Cell Proliferation,
pubmed-meshheading:17127713-Electrophoretic Mobility Shift Assay,
pubmed-meshheading:17127713-Female,
pubmed-meshheading:17127713-Ferritins,
pubmed-meshheading:17127713-Gene Expression Regulation,
pubmed-meshheading:17127713-Humans,
pubmed-meshheading:17127713-Iron,
pubmed-meshheading:17127713-Iron Regulatory Protein 1,
pubmed-meshheading:17127713-Lung Neoplasms,
pubmed-meshheading:17127713-Mice,
pubmed-meshheading:17127713-Mice, Inbred BALB C,
pubmed-meshheading:17127713-Mice, Nude,
pubmed-meshheading:17127713-Mutation,
pubmed-meshheading:17127713-Spectrophotometry, Atomic,
pubmed-meshheading:17127713-Transplantation, Heterologous,
pubmed-meshheading:17127713-Tumor Cells, Cultured,
pubmed-meshheading:17127713-Up-Regulation
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Overexpression of iron regulatory protein 1 suppresses growth of tumor xenografts.
|
|
pubmed:affiliation |
Lady Davis Institute for Medical Research, Sir Mortimer B. Davis Jewish General Hospital, 3755 Cote-Ste-Catherine Road, Montreal, Quebec, Canada H3T 1E2.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
